NAPROXEN Side Effects

6879939-3 | Blister, Skin Mass
on Jul 14, 2010 Male patient from UNITED KINGDOM , 47 years of age, weighting 172.0 lb, was diagnosed with arthralgia and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: blister, skin mass. Naproxen dosage: . During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6879862-4 | Blister, Skin Mass
Patient was taking Naproxen (View Usage). Patient had the following side effects: blister, skin mass on Jul 14, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 47 years of age, weighting 172.0 lb, was diagnosed with arthralgia and. Naproxen dosage: . During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6877166-7 | Asthenia, Dyspnoea Exertional, Gastric Ulcer, Presyncope, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Jul 27, 2010 by a Male patient taking Naproxen (View Usage) (Dosage: 500mg Bid Po) was diagnosed with pain (What is pain?), cardiovascular disorder and. Location: UNITED STATES , 82 years of age, After Naproxen was administered, patient had the following side effects: asthenia, dyspnoea exertional, gastric ulcer, presyncope, upper gastrointestinal haemorrhage. During the same period patient was treated with ASPIRIN (81mg Daily Po) (View Aspirin Review and Aspirin Label ), XALATAN OPHTH DROPS (View Xalatan Ophth Drops Review and Xalatan Ophth Drops Label ). Patient was hospitalized.

6865613-6 | Asthenia, Faeces Discoloured, Faeces Hard, Gastrointestinal Ulcer, Hypotension, Occult Blood Positive
on Jul 09, 2010 Female patient from DENMARK , 59 years of age, was diagnosed with arthropathy and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, faeces discoloured, faeces hard, gastrointestinal ulcer, hypotension, occult blood positive. Naproxen dosage: Prn. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), IBUX (View Ibux Review and Ibux Label ), ETALPHA (View Etalpha Review and Etalpha Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), DIOVAN (View Diovan Review and Diovan Label ), PROGRAF (View Prograf Review and Prograf Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.


6860432-9 | Pseudolymphoma, Rash Maculo-papular, Skin Lesion
on Jul 05, 2010 Male patient from GERMANY , 65 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Naproxen (View Usage). Patient had the following side effects: pseudolymphoma, rash maculo-papular, skin lesion. Naproxen dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), TOLTERODINE (View Tolterodine Review and Tolterodine Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6860298-7 | Upper Gastrointestinal Haemorrhage
Patient was taking Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: upper gastrointestinal haemorrhage on Jul 19, 2010 from UNITED STATES Additional patient health information: Male patient , 85 years of age, weighting 213.0 lb, was diagnosed with pain (What is pain?), aortic aneurysm (What is aortic aneurysm?), cerebrovascular accident and. Naproxen dosage: 250 Mg Bid Po. During the same period patient was treated with ASPIRIN (81 Mg Every Day Po) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6856577-X | Blister, Skin Mass
Adverse event was reported on Jul 14, 2010 by a Male patient taking Naproxen (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 47 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: blister, skin mass. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6856492-1 | Pseudolymphoma, Rash Maculo-papular, Skin Lesion
on Jul 05, 2010 Male patient from GERMANY , 65 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Naproxen (View Usage). Patient had the following side effects: pseudolymphoma, rash maculo-papular, skin lesion. Naproxen dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), TOLTERODINE (View Tolterodine Review and Tolterodine Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6836122-5 | Pseudolymphoma
on Jul 07, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 65 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: pseudolymphoma. Naproxen dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), TOLTERODINE (View Tolterodine Review and Tolterodine Label ), ACARBOSE (View Acarbose Review and Acarbose Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6835388-5 | Hypokalaemia, Hyponatraemia, Osmotic Demyelination Syndrome
Patient was taking Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, hyponatraemia, osmotic demyelination syndrome on Jul 01, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 160.9 lb, was diagnosed with arthralgia and. Naproxen dosage: Total Daily Dose: 440 Mg. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (50/12.5 Mg/day) (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DESLORATADINE (Total Daily Dose: 1000 Mg) (View Desloratadine Review and Desloratadine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (Total Daily Dose: 250 Mg) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

6832353-9 | Hypokalaemia, Hyponatraemia
Adverse event was reported on Jun 28, 2010 by a Female patient taking Naproxen (View Usage) (Dosage: ) was diagnosed with arthralgia and. Location: UNITED STATES , 59 years of age, weighting 160.9 lb, Patient had the following side effects: hypokalaemia, hyponatraemia. During the same period patient was treated with HYDROCHLOROTHIAZIDE W/LOSARTAN (Losartan 50mg/hydrochlorothiazide 12.5mg Per Day) (View Hydrochlorothiazide W/losartan Review and Hydrochlorothiazide W/losartan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (Amoxicillin 500mg/clavulanate 125 Mg Twice Daily) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

6832342-4 | Hypokalaemia, Hyponatraemia
on Jun 28, 2010 Female patient from UNITED STATES , 59 years of age, weighting 160.9 lb, was diagnosed with arthralgia and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: hypokalaemia, hyponatraemia. Naproxen dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE W/LOSARTAN (Losartan 50mg/hydrochlorothiazide 12.5mg Per Day) (View Hydrochlorothiazide W/losartan Review and Hydrochlorothiazide W/losartan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (Amoxicillin 500mg/clavulanate 125 Mg Twice Daily) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

6830805-9 | Anaemia, Dizziness, Gastric Haemorrhage
on Jul 09, 2010 Male patient from UNITED STATES , 54 years of age, was diagnosed with pain (What is pain?) and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dizziness (What is dizziness?), gastric haemorrhage. Naproxen dosage: 1000mg Bid Po.

6826913-9 | Pseudolymphoma
Patient was taking Naproxen (View Usage). Patient had the following side effects: pseudolymphoma on Jul 05, 2010 from CHINA Additional patient health information: Male patient , 65 years of age, . Naproxen dosage: .

6822751-1 | Gastric Ulcer, Haemoglobin Decreased, Rash, Skin Ulcer
Adverse event was reported on Jul 02, 2010 by a Female patient taking Naproxen (View Usage) (Dosage: Formulation: Peroral Agent.) was diagnosed with lung adenocarcinoma and. Location: JAPAN , weighting 116.0 lb, After Naproxen was administered, patient had the following side effects: gastric ulcer, haemoglobin decreased, rash (What is rash?), skin ulcer. During the same period patient was treated with ERLOTINIB (View Erlotinib Review and Erlotinib Label ), MYSLEE (View Myslee Review and Myslee Label ), ASTOMIN (Formulation: Peroral Agent.) (View Astomin Review and Astomin Label ), ALTAT (View Altat Review and Altat Label ), FERROMIA (Formulation: Peroral Agent.) (View Ferromia Review and Ferromia Label ). Patient was hospitalized.

6815227-9 | Gastric Haemorrhage
on Jul 01, 2010 Male patient from UNITED STATES , 67 years of age, weighting 197.3 lb, was diagnosed with pain (What is pain?), coronary artery disease (What is coronary artery disease?) and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: gastric haemorrhage. Naproxen dosage: 500 Mg Bid Po. During the same period patient was treated with ASPIRIN (325 Mg Every Day Po) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6814549-5 | Cough, Hypokalaemia, Hyponatraemia, Hypovolaemia, Locked-in Syndrome, Osmotic Demyelination Syndrome, Pneumonia Aspiration, Sinus Congestion, Staphylococcal Sepsis
on Jun 30, 2010 Female patient from , 59 years of age, weighting 160.9 lb, was diagnosed with arthralgia, hypokalaemia, hyponatraemia and was treated with Naproxen (View Usage). Patient had the following side effects: cough, hypokalaemia, hyponatraemia, hypovolaemia, locked-in syndrome, osmotic demyelination syndrome, pneumonia aspiration, sinus congestion, staphylococcal sepsis. Naproxen dosage: 440 Mg. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), SIMVASTATIN (5 Mg) (View Simvastatin Review and Simvastatin Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PHOSPHATE (View Phosphate Review and Phosphate Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ). Patient was hospitalized.

6813230-6 | Suicide Attempt
Patient was taking Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: suicide attempt on Jun 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 133.0 lb, was diagnosed with back pain (What is back pain?), anxiety (What is anxiety?) and. Naproxen dosage: . During the same period patient was treated with XANAX (Unk) (View Xanax Review and Xanax Label ).

6803351-6 | Biliary Colic, Cholelithiasis
Adverse event was reported on Jun 17, 2010 by a Female patient taking Naproxen (View Usage) (Dosage: ) was diagnosed with osteoarthritis (What is osteoarthritis?) and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: biliary colic, cholelithiasis. Patient was hospitalized.

6785988-6 | Convulsion, Headache, Product Substitution Issue
on Jun 22, 2010 Male patient from UNITED STATES , weighting 196.0 lb, was diagnosed with headache (What is headache?) and was treated with Naproxen (View Usage). Patient had the following side effects: convulsion, headache (What is headache?), product substitution issue. Naproxen dosage: 500 Mg As Needed Po. During the same period patient was treated with SUMATRIPTAN SUCCINATE (85 Mg As Needed Po) (View Sumatriptan Succinate Review and Sumatriptan Succinate Label ), TREXIMET (View Treximet Review and Treximet Label ). Patient was hospitalized.

6774717-8 | Coagulopathy, Eosinophil Count Increased, Face Oedema, Hepatitis Acute, Hepatosplenomegaly, Hyponatraemia, Jaundice, Lymphadenopathy
on Jun 08, 2010 Male patient from GERMANY , child 11 years of age, was diagnosed with arthritis (What is arthritis?) and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: coagulopathy, eosinophil count increased, face oedema, hepatitis acute, hepatosplenomegaly, hyponatraemia, jaundice (What is jaundice?), lymphadenopathy. Naproxen dosage: . During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ). Patient was hospitalized.

6771515-6 | Diverticulum
Patient was taking Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: diverticulum on Jun 03, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Naproxen dosage: .

6767814-4 | Accidental Overdose, Respiratory Depression
Adverse event was reported on Jun 09, 2010 by a Male patient taking Naproxen (View Usage) (Dosage: ) was diagnosed with toothache and. Location: UNITED KINGDOM , 28 years of age, weighting 403.4 lb, Patient had the following side effects: accidental overdose, respiratory depression. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), NORDIAZEPAM (View Nordiazepam Review and Nordiazepam Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), OXYCODONE HYDROCHLORIDE (View Oxycodone Hydrochloride Review and Oxycodone Hydrochloride Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

6767406-7 | Heart Rate Increased, Hypotension, Pupillary Reflex Impaired, Visual Impairment
on Jun 11, 2010 Female patient from UNITED STATES , weighting 165.0 lb, was diagnosed with carpal tunnel syndrome (What is carpal tunnel syndrome?) and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: heart rate increased, hypotension, pupillary reflex impaired, visual impairment. Naproxen dosage: 1 Twice Daily Po. Patient was hospitalized.

6762429-6 | Bradycardia
on May 27, 2010 Male patient from UNITED STATES , 84 years of age, weighting 152.1 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia. Naproxen dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), MOTRIN (View Motrin Review and Motrin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENICAR (View Benicar Review and Benicar Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), INOSITOL (View Inositol Review and Inositol Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

6758581-9 | Intestinal Diaphragm Disease
Patient was taking Naproxen (View Usage). Patient had the following side effects: intestinal diaphragm disease on May 31, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, . Naproxen dosage: . During the same period patient was treated with METHADONE (View Methadone Review and Methadone Label ). Patient was hospitalized.

6758276-1 | Abdominal Pain Lower, Constipation, Gastrointestinal Disorder, Intestinal Diaphragm Disease, Intestinal Obstruction, Mucosal Ulceration, Nausea
Adverse event was reported on Jun 01, 2010 by a Female patient taking Naproxen (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , 46 years of age, After Naproxen was administered, patient had the following side effects: abdominal pain lower, constipation (What is constipation?), gastrointestinal disorder, intestinal diaphragm disease, intestinal obstruction, mucosal ulceration, nausea (What is nausea?). During the same period patient was treated with METHADONE (View Methadone Review and Methadone Label ).

6751042-2 | Anaemia, Gastrointestinal Haemorrhage
on May 28, 2010 Female patient from UNITED KINGDOM , 70 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, gastrointestinal haemorrhage. Naproxen dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LOTREL (View Lotrel Review and Lotrel Label ), K TAB (View K-tab Review and K-tab Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ). Patient was hospitalized.

6749233-X | Gastrointestinal Haemorrhage, Haematochezia
on May 25, 2010 Female patient from UNITED STATES , 72 years of age, was treated with Naproxen (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, haematochezia. Naproxen dosage: . During the same period patient was treated with FLUIDS (View Fluids Review and Fluids Label ). Patient was hospitalized.

6734682-6 | Anaemia, Chest Pain, Gastric Haemorrhage, Gastrointestinal Haemorrhage
Patient was taking Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: anaemia, chest pain (What is chest pain?), gastric haemorrhage, gastrointestinal haemorrhage on May 19, 2010 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 176.4 lb, was diagnosed with pain (What is pain?) and. Naproxen dosage: 500 Mg Bid Po. Patient was hospitalized.

6716193-7 | Dyspnoea, Haematoma, Lip And/or Oral Cavity Cancer, Post Procedural Haemorrhage, Upper Airway Obstruction
Adverse event was reported on May 06, 2010 by a Male patient taking Naproxen (View Usage) (Dosage: 1000 Mg) was diagnosed with depression (What is depression?) and. Location: , 53 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, haematoma, lip and/or oral cavity cancer, post procedural haemorrhage, upper airway obstruction. During the same period patient was treated with SERTRALINE HCL (100 Mg) (View Sertraline Hcl Review and Sertraline Hcl Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ).

6715473-9 | Asthenia, Dizziness, Gastric Ulcer, Haemoglobin Decreased, Melaena
on May 06, 2010 Male patient from UNITED STATES , 79 years of age, weighting 219.1 lb, was diagnosed with pain (What is pain?) and was treated with Naproxen (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), gastric ulcer, haemoglobin decreased, melaena. Naproxen dosage: Po Out Pt Use. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOCUSATE (View Docusate Review and Docusate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6715089-4 | Migraine
on Apr 23, 2010 Female patient from NETHERLANDS , 60 years of age, weighting 143.3 lb, was diagnosed with procedural pain and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: migraine (What is migraine?). Naproxen dosage: .

6715088-2 | Migraine
Patient was taking Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?) on Apr 23, 2010 from NETHERLANDS Additional patient health information: Female patient , 60 years of age, weighting 143.3 lb, was diagnosed with procedural pain and. Naproxen dosage: .

6711708-7 | Adrenal Insufficiency, Constipation, Deep Vein Thrombosis, Haemorrhage, Hyperkalaemia, Hyponatraemia, Hypotension, International Normalised Ratio
Adverse event was reported on Apr 29, 2010 by a Male patient taking Naproxen (View Usage) (Dosage: ) was diagnosed with constipation (What is constipation?), pulmonary embolism (What is pulmonary embolism?) and. Location: UNITED KINGDOM , 46 years of age, Patient had the following side effects: adrenal insufficiency, constipation (What is constipation?), deep vein thrombosis (What is deep vein thrombosis?), haemorrhage, hyperkalaemia, hyponatraemia, hypotension, international normalised ratio. During the same period patient was treated with POLYETHYLENE GLYCOL 3350 (I Days) (View Polyethylene Glycol 3350 Review and Polyethylene Glycol 3350 Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DEXAMETASONE (Other Indication: Routine Health Maintenance, Dose : 2 Mg, 4 Mg) (View Dexametasone Review and Dexametasone Label ), WARFARIN SODIUM (Other Indication: Deep Vein Thrombosis) (View Warfarin Sodium Review and Warfarin Sodium Label ), DIAMORPHINE (Dose 100 Mg, Duration 1 Day) (View Diamorphine Review and Diamorphine Label ), MIDAZOLAM HCL (Dose 10 Mg, Duration 1 Day.) (View Midazolam Hcl Review and Midazolam Hcl Label ), KETAMINE (View Ketamine Review and Ketamine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6709623-8 | Orthostatic Hypotension, Syncope, Weight Decreased
on Apr 28, 2010 Female patient from UNITED KINGDOM , 55 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: orthostatic hypotension, syncope, weight decreased. Naproxen dosage: . During the same period patient was treated with STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ).

6709085-0 | Duodenal Ulcer, Gastrointestinal Haemorrhage
on May 03, 2010 Male patient from UNITED STATES , 52 years of age, weighting 215.4 lb, was diagnosed with pain (What is pain?) and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal ulcer, gastrointestinal haemorrhage. Naproxen dosage: 500 Mg Bid Po. Patient was hospitalized.

6706228-X | Faeces Discoloured
Patient was taking Naproxen (View Usage). Patient had the following side effects: faeces discoloured on Apr 14, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Naproxen dosage: .

6706227-8 | Bone Tuberculosis
Adverse event was reported on Apr 16, 2010 by a Male patient taking Naproxen (View Usage) (Dosage: ) . Location: UNITED KINGDOM , child 5 years of age, After Naproxen was administered, patient had the following side effects: bone tuberculosis. During the same period patient was treated with BACILLUS CALMETTE GUERIN (View Bacillus Calmette-guerin Review and Bacillus Calmette-guerin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS HYDRATE (View Tacrolimus Hydrate Review and Tacrolimus Hydrate Label ).

6701858-3 | Bone Tuberculosis
on Apr 16, 2010 Male patient from UNITED KINGDOM , child 5 years of age, was diagnosed with langerhans' cell histiocytosis and was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: bone tuberculosis. Naproxen dosage: . During the same period patient was treated with BACILLUS CALMETTE GUERIN (View Bacillus Calmette-guerin Review and Bacillus Calmette-guerin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS HYDRATE (View Tacrolimus Hydrate Review and Tacrolimus Hydrate Label ).

6701857-1 | Faeces Discoloured
on Apr 14, 2010 Female patient from UNITED STATES , 66 years of age, was treated with Naproxen (View Usage). Patient had the following side effects: faeces discoloured. Naproxen dosage: .

6697194-4 | Suicide Attempt
Patient was taking Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: suicide attempt on Apr 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 133.0 lb, was diagnosed with back pain (What is back pain?), anxiety (What is anxiety?) and. Naproxen dosage: . During the same period patient was treated with XANAX (Unk) (View Xanax Review and Xanax Label ).

6697071-9 | Asthenia, Dyspnoea, Haemoglobin Decreased, Melaena
Adverse event was reported on Apr 22, 2010 by a Female patient taking Naproxen (View Usage) (Dosage: 500 Mg;bid;po Purepac) was diagnosed with sciatica (What is sciatica?) and. Location: UNITED KINGDOM , 64 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, dyspnoea, haemoglobin decreased, melaena. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ). Patient was hospitalized.

6690245-2 | Bone Tuberculosis
on Apr 16, 2010 Male patient from JAPAN , child 5 years of age, was diagnosed with langerhans' cell histiocytosis and was treated with Naproxen (View Usage). Patient had the following side effects: bone tuberculosis. Naproxen dosage: . During the same period patient was treated with BACILLUS CALMETTE GUERIN (View Bacillus Calmette-guerin Review and Bacillus Calmette-guerin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETASONE (View Dexametasone Review and Dexametasone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS HYDRATE (View Tacrolimus Hydrate Review and Tacrolimus Hydrate Label ).

6689398-1 | Renal Failure Acute
on Apr 19, 2010 Male patient from UNITED STATES , 55 years of age, weighting 217.2 lb, was diagnosed with pain (What is pain?) and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: renal failure acute. Naproxen dosage: 250 Mg Bid Po. Patient was hospitalized.

6688342-0 | Orthostatic Hypotension, Syncope, Weight Decreased
Patient was taking Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: orthostatic hypotension, syncope, weight decreased on Apr 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Naproxen dosage: . During the same period patient was treated with STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ).

6678895-0 | Adverse Event, Gouty Arthritis, Muscle Spasms, Oesophageal Disorder, Stress
Adverse event was reported on Mar 10, 2010 by a Female patient taking Naproxen (View Usage) (Dosage: ) . Location: UNITED STATES , 74 years of age, Patient had the following side effects: adverse event, gouty arthritis, muscle spasms, oesophageal disorder, stress (What is stress?). During the same period patient was treated with VALIUM (View Valium Review and Valium Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

6678818-4 | Bone Tuberculosis
on Mar 29, 2010 Male patient from UNITED KINGDOM , child 5 years of age, was diagnosed with langerhans' cell histiocytosis and was treated with Naproxen (View Usage). After Naproxen was administered, patient had the following side effects: bone tuberculosis. Naproxen dosage: . During the same period patient was treated with BACILLUS CALMETTE GUERIN (View Bacillus Calmette-guerin Review and Bacillus Calmette-guerin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS HYDRATE (View Tacrolimus Hydrate Review and Tacrolimus Hydrate Label ).

6675524-7 | Anaemia, Gastrointestinal Haemorrhage
on Mar 29, 2010 Male patient from UNITED KINGDOM , 92 years of age, was treated with Naproxen (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, gastrointestinal haemorrhage. Naproxen dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6671758-6 | Hyperkalaemia, Hyponatraemia, Tumour Haemorrhage
Patient was taking Naproxen (View Usage). Patient had the following side effects: hyperkalaemia, hyponatraemia, tumour haemorrhage on Mar 24, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 46 years of age, was diagnosed with metastatic malignant melanoma, fatigue, pulmonary embolism (What is pulmonary embolism?) and. Naproxen dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DIAMORPHINE (View Diamorphine Review and Diamorphine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), KETAMINE (View Ketamine Review and Ketamine Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).